Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

52 results about "Medication interaction" patented technology

Drug interaction prediction method based on multilayer attention and elastic message passing

The invention relates to the technical field of drug interaction prediction, and discloses a drug interaction prediction method based on multilayer attention and elastic message passing, which comprises the following steps: firstly, extracting graph structure information of drug molecules from a 3D structure of the drug molecules, including associated features of atoms and chemical bonds; on the atomic feature level, learning updating and denoising of different atom and chemical bond features in drug molecules are achieved by using an elastic graph neural network and fusing the attention mechanism of Transform and combining a 3D position coding method based on the molecular mass center; on the molecular feature level, the attention mechanism is further utilized, and through supervised learning, comparative learning and structured learning, the potential interaction relationship of different drug molecules is mined, and potential network attacks are detected and defended; and interaction prediction of any two drug molecules i and j is realized. The results of four indexes of ACC, AUC, AP and F1 all reach 98% or above, and the method exceeds the most advanced method at present.
Owner:CHONGQING MEDICAL UNIVERSITY

Drug-drug interaction prediction method based on drug flow subgraph

The invention discloses a drug-drug interaction prediction method based on a drug flow sub-graph, and relates to the technical field of bioinformatics, and the method comprises the steps: data preparation: collecting a reference data set including drug-drug interaction, and introducing an external knowledge graph for adaptability preprocessing; constructing a model: constructing a drug-drug interaction prediction model, and training by using the preprocessed reference data set; and effect prediction: inputting a target drug into the drug-drug interaction prediction model, and outputting a drug-drug interaction prediction result through the drug-drug interaction prediction model. The structure and semantic information of the drug flow sub-graph are fully utilized, accurate prediction of drug interaction is realized, and the prediction efficiency is improved. And the interpretability of the drug-drug interaction prediction model is improved.
Owner:CHENGDU UNIV OF INFORMATION TECH

Use of maribavir in treatment regimens

Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
Owner:TAKEDA PHARMA CO LTD

Drug interaction prediction method based on double-view graph neural network

The invention discloses a drug interaction prediction method based on a double-view graph neural network, and the method comprises the steps: extracting features in a single drug view in a self-adaptive manner through a directional message passing neural network with a substructure attention mechanism, and extracting interaction features between the drug and the view through a graph attention network; and fusing to generate drug substructure features, so as to more accurately predict the interaction between drugs. And through the common attention mechanism module, drug interaction is converted into pairwise interaction between drug substructures, so that the capability of capturing drug molecular characteristics is greatly enhanced, and the prediction precision is improved. The invention can make full use of the interaction information between drugs and the interaction information of chemical substructures, studies the classification and identification problem of drug interaction prediction, and provides an efficient drug interaction prediction method.
Owner:HENAN UNIVERSITY

Drug interaction prediction method based on multi-dimensional features

The invention discloses a drug interaction prediction method based on multi-dimensional features, and relates to the technical field of drug interaction prediction, and the method comprises the following steps: S1, collecting multi-dimensional feature information of drugs from authoritative databases DrubBank, KEGG and Pubchemm, and obtaining drug features; meanwhile, real clinical case data are collected and recorded as clinical data. According to the drug interaction prediction method based on the multi-dimensional features, through ensemble learning and model fusion, by means of complementary advantages of different models, reasonable screening and weighted features, the models can keep relatively stable performance in different data sets and application scenes, model prediction deviation caused by data fluctuation or feature change is reduced, and the prediction accuracy of drug interaction is improved. The generalization ability of the model is enhanced, the applicability and reliability of the model in actual drug interaction prediction are improved, and the probability that a single model generates a false positive result is reduced.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Drug recommendation model construction method, drug recommendation method, device and equipment

The invention discloses a drug recommendation model construction method, a drug recommendation method, a drug recommendation device and drug recommendation equipment, and belongs to the technical field of drug recommendation. The method comprises the following steps: constructing an EDRMM model; then constructing a loss function including binary cross entropy loss, multi-label prediction loss, drug interaction loss and regularization constraint terms; constructing a training sample set; and then training an EDRMM model by using the training sample set and the loss function to obtain a trained EDRMM model as a drug recommendation model. The fine-grained electronic health record data, the historical electronic health record selection process and the regularization constraint term are introduced, noise of the historical attribute data is reduced, the DDI occurrence risk rate is better controlled, and the drug recommendation quality is improved.
Owner:XIAMEN UNIV +1

Method and system for predicting drug interaction based on graph neural network and multiple attention mechanisms

The invention discloses a drug interaction prediction method and system based on a graph neural network and multiple attention mechanisms. The method comprises the following steps: converting an SMILES sequence of a drug pair into graph data, and obtaining an embedding matrix of the drug pair by utilizing a multi-layer GIN operation; extracting a self-attention feature matrix of the drug pair from the embedding matrix of the drug through a self-attention mechanism encoder, calculating a cosine similarity matrix of the drug pair, and obtaining a self-attention feature vector of the drug pair after leveling operation; processing the embedded matrix of the drug pair through an interactive attention mechanism encoder to obtain a feature matrix with interactive attention coefficients, performing average pooling operation on the interactive attention coefficient feature matrixes of the two drugs, and then performing standardization to obtain an interactive feature vector of the drug pair; and carrying out splicing operation on the self-attention feature vectors and the interaction feature vectors of the drug pairs, and inputting a multi-layer perceptron to predict the interaction between the drug pairs. According to the invention, the interaction between drugs can be better predicted.
Owner:HUNAN UNIV OF CHINESE MEDICINE

AI reminding method for gastroenterology department enteroscope patient to take laxative

The invention relates to the technical field of medical health and artificial intelligence, and discloses an AI reminding method for a gastroenterology department enteroscope patient to take a laxative, comprising the following steps: S1, guiding the patient to enter an AI interaction interface through a two-dimensional code or an applet entry; s2, generating a personalized medication scheme according to the basic information and the real-time data input by the patient; s3, ensuring that the patient completes an intestinal tract preparation process through a staged guidance and real-time reminding function; s4, performing abnormal reaction identification according to real-time feedback data input by the patient, and adjusting subsequent operation suggestions; and S5, screening potential drug interaction through the integrated drug database, and providing a safe drug use prompt. Personalized data such as age, weight, basic diseases, daily medication and daily work and rest of a patient are collected through the personal information input module, the medication scheme generation module calls a preset algorithm to calculate the optimal medication dosage, medication time nodes are determined, and diet suggestions are generated.
Owner:NINGBO FIRST HOSPITAL

System and method for vibration-based medication interaction recognition

A system and method for monitoring medication intake uses vibration signals generated by a kinetic augmentation attachment. The attachment includes a base coupled to a medication container, a spring, and a weight, which produces distinct vibration signatures when the container is placed on a surface. A vibration sensor detects these signals, and a computing device processes them to extract features of the attachment and identify the medication container. The system does not require batteries, enabling long-term, maintenance-free monitoring. The method includes processing vibration signals using frequency analysis and machine learning to recognize different medication containers based on their kinetic signatures.
Owner:RGT UNIV OF CALIFORNIA

Intelligent reminding and management system for medication compliance of chronic diseases of old people

The invention relates to the technical field of elderly chronic disease medication management, and discloses an elderly chronic disease medication compliance intelligent reminding and management system. The system comprises an individualized medication modeling unit for establishing an individual pharmacodynamic model containing medication taboo and dosage rules based on an electronic health record of a patient and pharmacokinetic parameters; the multi-modal behavior sensing unit is used for collecting physiological data and movement tracks through wearable equipment, and generating a medication behavior sequence in combination with the record of the intelligent medicine box; the compliance deviation analysis unit is used for comparing an expected behavior with an actual behavior to calculate indexes such as a time matching degree and dose deviation; the risk decision engine unit is used for outputting an intervention level and a reminding strategy in combination with the deviation index, the physiological state and drug interaction; and the cross-platform collaborative execution unit triggers multi-channel reminding, medicine box locking and emergency contact notification. According to the system, the whole medication management process is intelligent, and the medication compliance and safety of the elderly patients are improved.
Owner:SECOND MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL

Drug interaction screening method based on drug use records

The invention belongs to the technical field of medical information, and relates to a drug interaction screening method based on drug use records. The core structure comprises: a data integration module, which obtains a multi-source medication record of a patient in real time through an HL7 / FHIR interface and carries out structured processing; the metabolism engine calculation module is used for identifying a metabolism action mode based on the drug-metabolic enzyme influence relation database and quantifying a net effect value by adopting a dynamic time weighting algorithm; the risk decision module is used for integrating liver and kidney functions and gene polymorphism data and generating a three-dimensional risk matrix through a multi-factor prediction model; and the clinical output module is used for executing risk visualization early warning, alternative medicine recommendation and individualized monitoring scheme generation. Dynamic medication time sequence analysis, individualized risk quantification and clinical decision closed-loop management are realized, and medication safety is improved.
Owner:周明敏

Systems and methods for drug interaction analysis

The present disclosure relates to systems and methods for analyzing drug-drug and gene-drug interactions of a user and providing suggestions therefrom. The systems and methods may utilize a database containing a list of genes associated with a plurality of drugs based on clinical relevance of the genes to the effects of the plurality of drugs. The systems and methods may include recommending alternative drugs to a user based on any identified problematic drug-drug or gene-drug interactions.
Owner:BLUE GENES LAB LLC

Systems and methods for drug interaction analysis

The present disclosure is directed to systems and methods for analyzing drug-drug and gene-drug interactions for a user and providing recommendations accordingly. The systems and methods can utilize a database comprising a list of genes are associated with a plurality of drugs based on clinical relevance of the gene to the actions of the plurality of drugs. The systems and methods can include recommending alternative drugs to users based on any identified problematic drug-drug or gene-drug interactions.
Owner:BLUE GENES LAB LLC

A Drug Interaction Prediction Method Based on Bidirectional Cross-Perspective Attention Network

PendingCN122091273Areduce sparsityAchieve two-way complementarityBiological modelsDrug referencesPersonalizationDrug interaction
This invention provides a drug interaction prediction method based on a bidirectional cross-view attention network, belonging to the field of drug interaction prediction technology. The method first constructs a Morgan fingerprint similarity view of the drug, an original DDI view, and a multi-scale diffusion view based on personalized PageRank. Then, a graph convolutional network with shared weights is used to co-encode the multiple views, generating a unified drug embedding representation. Finally, a bidirectional cross-view attention mechanism is used to achieve fine-grained interaction and alignment between the structural and attribute views, and interaction prediction is completed via a multilayer perceptron. This invention effectively alleviates the sparsity problem of the DDI network through multi-scale topology enhancement and achieves complementary enhancement between views using bidirectional cross-view attention, significantly improving the accuracy and generalization ability of drug interaction prediction. It can provide reliable technical support for drug development screening and clinical combined drug safety assessment.
Owner:XIAMEN UNIV OF TECH

A drug interaction prediction method based on DS evidence theory

The application discloses a drug interaction prediction method based on DS evidence theory. First, multi-modal data of drugs are acquired to construct a drug interaction dataset; then, multi-modal features of the drugs are extracted as inputs of a deep neural network, a multi-modal drug interaction prediction model is constructed, and the prediction model is trained; then, the trained prediction model is used to predict drug interactions. The prediction model uses Dirichlet distribution to calculate classification probability and uncertainty value, and obtains multi-modal prediction results and overall uncertainty value through Dempster-Shafer evidence theory fusion. Compared with existing prediction methods, the application uses multi-modal drug data, has a lower prediction error, can provide meaningful uncertainty information for guiding multi-modal prediction fusion and expressing prediction confidence, and has higher reliability and robustness.
Owner:GUILIN UNIVERSITY OF TECHNOLOGY

Drug interaction relationship prediction method based on LLMs and ICL

The invention provides a drug interaction relationship prediction method based on LLMs and ICL, belongs to the technical field of drug interaction relationship prediction, and solves the problems that a large language model is high in data set arrangement cost in the DDI-related characteristic prediction field, the generalization ability in a zero sample scene is limited, and the prediction efficiency is high. The method comprises the following steps: extracting a drug data sample, and making a data set; screening the drug data samples in the data set, and selecting the first K positive and negative sample drug pairs with the highest similarity; constructing a prompt of a drug relationship prediction model based on context learning and the selected positive and negative sample drug pairs; and mixing all the drug relationship prediction models by using MOE, evaluating scores of the drug relationship prediction models, and performing weighted fusion according to the scores to obtain a DDI final prediction result.
Owner:HARBIN INST OF TECH

Drug interaction prediction method and system based on meta-path length and type

The application discloses a drug interaction prediction method and system based on meta-path length and type, and the method comprises the following steps: constructing a heterogeneous graph; the heterogeneous graph mainly comprises a node set and an edge set; different node types in the node set and different edge types in the edge set are combined to form a sequence to describe a meta-path structure; each meta-path is coded, and a length factor of each meta-path is set to obtain a meta-path length; according to the meta-path length, the length of the lth meta-path is k, and the fusion meta-path features of each node are obtained; the fusion meta-path feature sets of all nodes are combined to obtain a fusion meta-path feature set; an interaction prediction model between drugs is set, the fusion meta-path features of two nodes in the fusion meta-path feature set are selected as input, and the probability of interaction between the two drugs is obtained through the interaction prediction model between the drugs. Through fine coding of the path length and type, the accuracy of DDI prediction is improved.
Owner:ANHUI MEDICAL UNIV

A method for early warning and dynamic intervention of medication risks in smart pillboxes for elderly patients with chronic diseases

This invention discloses a method for medication risk warning and dynamic intervention using a smart pillbox for elderly patients with chronic diseases, relating to the fields of intelligent medical devices and chronic disease management technology. The method first constructs four types of chronic disease knowledge graphs: medication behavior, physiological indicators, drug interactions, and environmental conditions. Then, it processes the graphs using a GNN module with a GRU-like gating mechanism, weightedly fusing multi-time-step features using a time-step attention mechanism, and integrating similar patient features based on Jaccard similarity to generate comprehensive risk features. During the training phase, the risk level and type are output after feature optimization using a collaborative attention mechanism. In the inference phase, a similarity propagation mechanism is used to address the cold-start problem for newly enrolled patients, matching a three-level intervention rule base to generate personalized strategies, and iteratively optimizing the model based on intervention feedback. This invention achieves proactive and precise warning and dynamic intervention, improving risk assessment performance and patient medication adherence in different scenarios.
Owner:QINGDAO HENGXING UNIV OF SCI & TECH

Mesh network coordination system for injectable medication administration and drug interaction prevention

A mesh network medication coordination system enables communication between intelligent injection devices, monitoring systems, patient devices, or healthcare provider devices to prevent adverse drug interactions in hospital settings. The system includes mesh network infrastructure supporting multiple networked devices, dosage measurement devices that directly measure or infer dosage administration including injection completion detection, medication volume measurement, administration timing data, or patient biometric responses, or a coordination module that coordinates medication administration timing across multiple devices. The system features drug interaction analysis capabilities, real-time monitoring of patient vital signs and medication effectiveness, alert generation for potential interactions and dosing conflicts, or data synchronization across all networked devices. This integrated approach optimizes dosing intervals, prevents conflicting medication schedules, synchronizes administration events, or maintains consistent medication administration data across the mesh network to enhance patient safety and treatment efficacy.
Owner:DATADOSE LLC

Boundary perception drug recommendation method based on deep model and large language model collaboration

The invention relates to a boundary perception drug recommendation method based on cooperation of a depth model and a large language model, and belongs to the technical field of medical artificial intelligence. The method comprises the following steps of: analyzing a doctor seeing record of a patient through a trained deep model, outputting a fine-grained drug prediction probability, and dividing candidate drugs into a boundary drug subset and a confidence drug subset according to a probability value; for boundary drugs with fuzzy decisions, enhanced information is constructed by retrieving similar historical electronic health archives and integrating drug interaction constraints, then special cue words are constructed to activate the semantic reasoning ability of a large language model, and the probability of the drugs of the subset is subjected to refined correction. And fusing the optimized boundary drug probability with a high-confidence drug prediction result given by the depth model to generate a final recommended prescription. According to the method, the drug interaction risk can be reduced while the recommendation accuracy is improved, and more accurate and safer personalized drug recommendation is realized.
Owner:FUZHOU UNIV

Clinical test medication operation system

The invention discloses a clinical test medication operation system, and relates to the technical field of clinical medication tests. Comprising a medication plan management end, a medication arrangement and scheduling end, a medication interaction check end, a medication record and data management end, a medication monitoring and safety evaluation end, a medication guidance and training end, an inventory management end, a medication approval and authorization management end, and a medication data analysis and report end. The medication plan management end, the medication arrangement and scheduling end, the medication interaction check end, the medication record and data management end, the medication monitoring and safety evaluation end, the medication guidance and training end, the inventory management end, the medication approval and authorization management end and the medication data analysis and report end are in data communication through a private network and a private line network. The method plays an important role in test drug management and monitoring, and is helpful for guaranteeing the quality and credibility of the test.
Owner:ANHUI SILICON LINYAN PHARMACEUTICAL TECHNOLOGY CO LTD

A method and system for drug recommendation with continuous training and drug-drug interaction constraints

PendingCN122455228ADiseaseDrug interaction
The application provides a drug recommendation method and system with continuous training and drug mutual constraint, relates to the technical field of medical health and artificial intelligence, and the method comprises the following steps: acquiring medical data to construct single-disease and multi-disease samples; a first model distribution of diseases and drugs in a single-disease scenario is obtained through self-attention mechanism pre-training; multi-disease samples are continuously iterated as units, a cross-attention mechanism is used to learn the joint influence of multi-disease and surgery on drugs, a drug interaction graph is introduced to calculate a drug conflict rate as a constraint term to construct a loss function to update the model, and a second model distribution is obtained; multi-disease samples are input into the trained model to output drug combination recommendation, and explanatory content is generated in combination with the drug interaction graph; the application learns single-disease correlation through pre-training, and introduces cross-attention and drug conflict rate constraint in continuous training, so that more accurate and safe drug combination recommendation in a multi-disease coexistence scenario is realized.
Owner:SHANDONG NORMAL UNIV

System and method of predicting efficacy of treatment

A system and method of predicting efficacy of treatment of a predetermined medical condition by at least one processor may include obtaining a Drug-Drug Interaction (DDI) embedding value, representing occurrence of DDIs between a substance of interest and one or more drugs selected from a plurality of baseline drugs, in a DDI embedding space; receiving a chemical structure data element, representing a chemical structure of the substance of interest; and predicting efficacy of the substance of interest in treatment of the predetermined medical condition based on (i) the DDI embedding value and (ii) the structure data element.
Owner:BG NEGEV TECHNOLOGIES & APPLICATIONS LTD

A boundary-aware drug recommendation method based on the collaboration of deep models and large language models

This invention relates to a boundary-aware drug recommendation method based on the collaboration of a deep learning model and a large language model, belonging to the field of medical artificial intelligence technology. The method analyzes patient medical records using a trained deep learning model, outputting fine-grained drug prediction probabilities, and dividing candidate drugs into a "boundary drug subset" and a "confidence drug subset" based on these probabilities. For boundary drugs with ambiguous decision-making, enhanced information is constructed by retrieving similar historical electronic health records and integrating drug interaction constraints. Then, specialized prompts are built to activate the semantic reasoning ability of the large language model, refining the probabilities of drugs in this subset. The optimized boundary drug probabilities are then fused with the high-confidence drug prediction results given by the deep learning model to generate the final recommended prescription. This invention can improve recommendation accuracy while reducing the risk of drug interactions, achieving more accurate and safer personalized medication recommendations.
Owner:FUZHOU UNIV

Drug interaction prediction method and system based on graph neural network and multiple attention mechanism

The application discloses a drug interaction prediction method and system based on a graph neural network and a multiple attention mechanism. The method comprises the following steps: converting SMILES sequences of a drug pair into graph data, and obtaining an embedding matrix of the drug pair by using a multilayer GIN operation; extracting a self-attention feature matrix of the drug pair from the embedding matrix of the drug by using a self-attention mechanism encoder, calculating a cosine similarity matrix of the drug pair, and obtaining a self-attention feature vector of the drug pair after a flattening operation; processing the embedding matrix of the drug pair by using an interactive attention mechanism encoder, obtaining an interactive attention coefficient feature matrix, performing average pooling operation on the interactive attention coefficient feature matrix of the two drugs respectively, then performing standardization, and then obtaining an interactive feature vector of the drug pair; and inputting the self-attention feature vector and the interactive feature vector of the drug pair into a multilayer perceptron to predict the interaction between the drug pair. The application can better predict the interaction between drugs.
Owner:HUNAN UNIV OF CHINESE MEDICINE

Method and electronic device for checking drug interactions

A method and an electronic device for checking drug interactions are provided. The method includes generating a first odds ratio between a first drug combination and an inpatient event, a second odds ratio between a second drug combination and the inpatient event, and a third odds ratio between a third drug combination and the inpatient event from a plurality of medical records; generating a first score corresponding to a first drug from the second odds ratio; generating a second score corresponding to a second drug from the third odds ratio; and outputting the first drug combination in response to the first odds ratio being greater than a first threshold, a sum of the first score and the second score being greater than a second threshold, and a quotient of the first score and the second score being less than a third threshold.
Owner:ACER INC +1

Perioperative medication auxiliary management method and device and electronic equipment

This invention discloses a method, device, and electronic device for perioperative medication management. The method includes: acquiring user time window data, surgery type data, surgical medication data, user basic data, and user long-term medication data; performing multidimensional cross-analysis on the surgery type data, surgical medication data, user basic data, and user long-term medication data to identify potential drug interactions and perioperative risk points; performing dynamic time-series analysis on potential drug interactions and perioperative risk points based on time window data to obtain medication adjustment suggestions for the user in any target time window; and generating targeted medication adjustment suggestions for any target time window. This achieves personalized and dynamic management of perioperative medication, effectively reducing the risk of drug interactions and improving the safety and rationality of perioperative medication.
Owner:RENMIN HOSPITAL OF WUHAN UNIVERSITY (HUBEI GENERAL HOSPITAL)

Clinical pharmacy knowledge graph construction method and medication conflict early warning system

The invention relates to the technical field of knowledge maps, in particular to a clinical pharmaceutical knowledge map construction method which comprises the following steps: S1, acquiring pharmaceutical knowledge data from a multi-source heterogeneous data source which comprises a drug specification database, a clinical diagnosis and treatment guide, a drug interaction professional literature, a pharmacological textbook and desensitized electronic medical record data; s2, performing entity recognition and relation extraction on the pharmaceutical knowledge data, and defining core entity types including drugs, chemical components, indications, adverse reactions, diseases, genes and drug use population characteristics; defining relationship types among entities, including incompatibility, drug interaction, pharmacodynamic synergy / antagonism, adverse reaction-drug association, drug-indication association and disease-drug incompatibility association; a multi-source fusion clinical pharmacy knowledge graph is constructed, accurate early warning of medication conflicts is realized through multi-modal intelligent reasoning, and the method has authority, interpretability and prospective risk discovery capabilities.
Owner:SHANGLUO CENT HOSPITAL